论文信息 - The efficacy of antiviral therapy after renal transplant in a HCV-positive recipient from a HCV-positive donor. - 字舞流文

The efficacy of antiviral therapy after renal transplant in a HCV-positive recipient from a HCV-positive donor.

G. Li Cavoli | F. Caputo | Vitalba Azzolina | R. Mongiovì | Barbara Oliva | Antonio Amato | R. Turdo | C. Carollo

[1] G. Manna. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs) , 2018 .

[2] M. Manns,et al. Treatment With LedipasvirSofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection , 2016, Annals of Internal Medicine.

[3] J. Hatch,et al. Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation , 2016, Cureus.

[4] N. Terrault,et al. Safety and efficacy of sofosbuvir‐containing regimens in hepatitis C‐infected patients with impaired renal function , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[5] J. Pawlotsky,et al. EASL Recommendations on Treatment of Hepatitis C 2016. , 2017, Journal of hepatology.